Nitinol Based Medical Device Market

Nitinol Based Medical Device Market

  • HC-48
  • 4.8 Rating
  • 260 Pages
  • 12-09-2023
  • 68 Reviews
  • PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

Market Outlook:

The Global Nitinol Based Medical Device Market was estimated at USD 17,612.2 Million in 2022 and is anticipated to reach USD ~ 46,274.6 Million by 2031, expanding at a CAGR of 11.8% during the forecast period.

Nitinol is an alloy composed of titanium (Ti) and Nickel (Ni) alloys. Nitinol has high elasticity and is resistant to corrosion. Nitinol (NiTi) is a shape memory alloy that has applications in several medical devices. A shape memory alloy regains its original shape after deformation. Several self-expanding implants, including stents and filters, use the thermal shape-memory property of nitinol for activation in the body. Some medical applications of nitinol include intravascular stents, radiofrequency interstitial tissue ablation device, orthodontic archwires, and inferior vena cava (IVC) filters.

Nitinol Based Medical Device Market Outlook

Macro-economic Factors

Government Policies

Governments play a crucial role in the overall development of a strong healthcare system in a region through the ministry of Health and other related ministries and agencies. Stringent policies of government determine the growth and decline of a specific market in a particular country. These government policies differ from country to country or region to region.

Government plays a significant part in the establishment of a prominent healthcare system by taking various initiatives and entering into partnerships with the private sector, nongovernmental organizations, and charitable institutions. Governments provide a broad framework and direction for all healthcare programs to be undertaken, depending on the epidemiological profile of the country. Government authorities decide whether to approve a drug or a medical device. Government approvals are mandatory for companies to launch a medication. Drug efficacy and safety of the medication are determined during clinical trials by the manufacturers.

Cost of Treatment

Cost of treatment is one of the significant factors that determine the affordability of a cure. It is calculated by dividing the total expenses by the number of unique patients to determine the average cost per patient per year. Developing countries are not able to provide treatment facilities for diseases, such as cancer. This is attributed to the fact that the cost of treatment is extremely high and the population or infrastructure of the developing countries does not have a strong financial basis for such therapies. Over the last few decades, advancement in medical technology has made it possible to cure diseases that were once considered incurable. However, the high cost of treatment makes it difficult for a middle-class person to afford the treatment. High cost of treatment has a major impact on the growth of a market.

Market Dynamics

Market Driver- Growing Prevalence of Cardiovascular Disease

Rising sedentary lifestyle has led to an increase in the number of diseases, especially cardiovascular diseases. According to the Centers for Disease Control (CDC), 30.3 million people in the US were affected by cardiovascular diseases in 2018. Increasing occurrence of cardiovascular diseases has propelled the expenditure on on surgical procedures, thereby, driving the demand for Nitinol Based Medical Devices. Nitinol Based Medical Devices are elastic and biocompatible; therefore, they are used as stents for treating cardiovascular diseases.

According to a recent estimate by the World Heart Federation, fatalities from cardiovascular diseases (CVDs), the main cause of death globally, increased 60% globally from 12.1 million in 1990 to 20.5 million in 2021. Globally, about 2% of deaths from cardiovascular diseases are related to rheumatic heart disease. Thus, the growing prevalence of cardiovascular disease is anticipated to boost the Nitinol Based Medical Device market over the forecast period.

Market Driver- Rising Demand for Minimally Invasive Surgical Procedures

A small incision is made in minimally invasive surgical procedures to minimize the damage done to the body. These procedures result in reduced pain than traditional surgeries. Chances of infections after these procedures are less, which, in turn, drives their demand. Nitinol Based devices have applications in laparoscopy. Nitinol Based devices reduce the occurrence of infections, which, in turn, boosts their usage in minimally invasive surgical procedures. Minimally invasive surgical procedures comprised 52% of procedures in 2020. 29% of minimally invasive surgeries in 2020 underwent complications.

Robotic surgery was widely and quickly adopted by hospitals that started robotic surgery programs; however, this was accompanied by a decline in traditional laparoscopic minimally invasive surgery.

Market Restraint- Recall of Medical Devices

Medical devices are recalled, due to defects in the design of these devices. Recall of medical devices hinders the growth of the market. According to the Food and Drug Administration, (FDA), the nitinol stent system and the S.M.A.R.T. control nitinol stent system were recalled in November 2019. These self-expanding nitinol stent systems are placed in the blood vessels. The diameter of the stents is small, which led to the recall of these devices.

During 2018, the average number of $58 million per unit the previous year (2017) rose to nearly 100 million units issued a recall each quarter, a massive jump of nearly 71%. Data indicates that approximately 17% of all medical device liability cases involve inadequate (defective) device designs. Thus, the recall of medical devices is expected to affect the market growth to some extent over the forecast period.

Market Opportunity- Technological Advancements in the Medical Device Industry

Advent of technology has led to an increase in the adoption of medical devices, thus boosting the market. Moreover, the introduction of medical devices is fueling the adoption of drug-eluting stents and Nitinol Based stents for the treatment of diseases, which, in turn, is driving the market.

Introduction of technologies, including resistance to corrosion, led to an increase in the adoption of medical devices. Medical devices, such as drug delivery systems, surgical robots, and diagnostic tools, use artificial intelligence (AI). AI is used to create treatments for diseases as well as increase the precision and effectiveness of these technologies. Custom medical devices such as implants, surgical instruments, and prosthetics are being manufactured using the 3D printing method. 3D printing is used to manufacture prototypes of new equipment rapidly, in addition to enabling the construction of devices that are customized to the specific requirements of patients.

Scope of the Report

The report on the Global Nitinol Based Medical Device Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
 

Attributes

Details

Report Title

Nitinol Based Medical Device Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Product (Nitinol Stents, Nitinol Guidewires, Nitinol Filters, Nitinol Basket, Nitinol Catheters, and Others), Application (Orthopedic, Vascular, Dental, Gastroenterology, and Others), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

Regional Scope

Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered

Abbott, ENDOSMART, Arthrex, Inc., B. Braun SE, BD, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, COOK MEDICAL LLC, Medtronic, Nordson Corporation, Olympus Corporation, steris plc, W. L. Gore & Associates, Inc., and Zimmer Biomet.

Segmental Outlook

Based on Product, the market is segmented into nitinol stents, nitinol guidewires, nitinol filters, nitinol basket, nitinol catheters, and others. The nitinol stents segment is expected to hold a considerable share of the market during the forecast. Nitinol stents are flexible, which allows them to be inserted into the twisting arteries.

Nitinol Based Medical Device Market Product

On the basis of Application, the market is fragmented into orthopedic, vascular, dental, gastroenterology, and others. The vascular segment holds a key share of the market. The orthopedic segment is anticipated to expand at a considerable pace during the forecast period. In orthopedic applications, nitinol bone screws are used to hold bones together after surgery. They are more flexible than traditional metal screws, which makes them less likely to cause damage to the bone.

Nitinol Based Medical Device Market Application

On the basis of End-user, the market is fragmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment holds a key share of the market, as hospitals are focusing on providing new therapies and treatments for diseases through their services.

Regional Outlook

Based on regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2022. The rising adoption of technologies and increasing disposable income of people in North America are fueling the adoption of Nitinol Based Medical Devices in the region.

Nitinol Based Medical Device Market Regions

Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Nitinol Based Medical Device Market

  • Historical, Current, and Projected Market Size in Terms of Value

  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

  • Industry Drivers, Restraints, and Opportunities Covered in the Study

  • Recent Industry Trends and Developments

  • Competitive Landscape & Strategies of Key Players

  • Neutral Perspective on Global Nitinol Based Medical Device Market

Segments

By Product

  • Nitinol Stents
  • Nitinol Guidewires
  • Nitinol Filters
  • Nitinol Basket
  • Nitinol Catheters
  • Others

By Application

  • Orthopedic
  • Vascular
  • Dental
  • Gastroenterology
  • Others

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Market Players Profiled in the Report

  • Abbott
  • ENDOSMART
  • Arthrex, Inc.
  • Braun SE
  • BD
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • COOK MEDICAL LLC
  • Medtronic
  • Nordson Corporation
  • Olympus Corporation
  • steris plc
  • W. L. Gore & Associates, Inc.
  • Zimmer Biomet

Competitive Landscape

  • Manufacturers operating in the Global Nitinol Based Medical Device Market are Abbott, ENDOSMART, Arthrex, Inc., B. Braun SE, BD, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, COOK MEDICAL LLC, Medtronic, Nordson Corporation, Olympus Corporation, steris plc, W. L. Gore & Associates, Inc., and Zimmer Biomet.

  • Market players are pursuing strategies such as acquisitions, product launches, collaborations, and geographic expansion to leverage untapped opportunities in the Global Nitinol Based Medical Device Market.

    Nitinol Based Medical Device Market Key Players

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nitinol Based Medical Device Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Nitinol Based Medical Device Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Nitinol Based Medical Device Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Nitinol Based Medical Device Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Nitinol Based Medical Device Market Size & Forecast, 2016-2031
      4.5.1 Nitinol Based Medical Device Market Size and Y-o-Y Growth
      4.5.2 Nitinol Based Medical Device Market Absolute $ Opportunity
Chapter 5 Global Nitinol Based Medical Device Market Analysis and Forecast By Product
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Product
      5.1.2 Basis Point Share (BPS) Analysis By Product
      5.1.3 Absolute $ Opportunity Assessment By Product
   5.2 Nitinol Based Medical Device Market Size Forecast By Product
      5.2.1 Nitinol Stents
      5.2.2 Nitinol Guidewires
      5.2.3 Nitinol Filters
      5.2.4 Nitinol Basket
      5.2.5 Nitinol Catheters
      5.2.6 Others
   5.3 Market Attractiveness Analysis By Product
Chapter 6 Global Nitinol Based Medical Device Market Analysis and Forecast By Application
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Application
      6.1.2 Basis Point Share (BPS) Analysis By Application
      6.1.3 Absolute $ Opportunity Assessment By Application
   6.2 Nitinol Based Medical Device Market Size Forecast By Application
      6.2.1 Orthopedic
      6.2.2 Vascular
      6.2.3 Dental
      6.2.4 Gastroenterology
      6.2.5 Others
   6.3 Market Attractiveness Analysis By Application
Chapter 7 Global Nitinol Based Medical Device Market Analysis and Forecast By End-user
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By End-user
      7.1.2 Basis Point Share (BPS) Analysis By End-user
      7.1.3 Absolute $ Opportunity Assessment By End-user
   7.2 Nitinol Based Medical Device Market Size Forecast By End-user
      7.2.1 Hospitals
      7.2.2 Clinics
      7.2.3 Ambulatory Surgical Centers
      7.2.4 Others
   7.3 Market Attractiveness Analysis By End-user
Chapter 8 Global Nitinol Based Medical Device Market Analysis and Forecast by Region
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities by Region
      8.1.2 Basis Point Share (BPS) Analysis by Region
      8.1.3 Absolute $ Opportunity Assessment by Region
   8.2 Nitinol Based Medical Device Market Size Forecast by Region
      8.2.1 North America
      8.2.2 Europe
      8.2.3 Asia Pacific
      8.2.4 Latin America
      8.2.5 Middle East & Africa (MEA)
   8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
   9.1 Introduction
   9.2 Current & Future Impact Analysis
   9.3 Economic Impact Analysis
   9.4 Government Policies
   9.5 Investment Scenario
Chapter 10 North America Nitinol Based Medical Device Analysis and Forecast
   10.1 Introduction
   10.2 North America Nitinol Based Medical Device Market Size Forecast by Country
      10.2.1 U.S.
      10.2.2 Canada
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 North America Nitinol Based Medical Device Market Size Forecast By Product
      10.6.1 Nitinol Stents
      10.6.2 Nitinol Guidewires
      10.6.3 Nitinol Filters
      10.6.4 Nitinol Basket
      10.6.5 Nitinol Catheters
      10.6.6 Others
   10.7 Basis Point Share (BPS) Analysis By Product
   10.8 Absolute $ Opportunity Assessment By Product
   10.9 Market Attractiveness Analysis By Product
   10.10 North America Nitinol Based Medical Device Market Size Forecast By Application
      10.10.1 Orthopedic
      10.10.2 Vascular
      10.10.3 Dental
      10.10.4 Gastroenterology
      10.10.5 Others
   10.11 Basis Point Share (BPS) Analysis By Application
   10.12 Absolute $ Opportunity Assessment By Application
   10.13 Market Attractiveness Analysis By Application
   10.14 North America Nitinol Based Medical Device Market Size Forecast By End-user
      10.14.1 Hospitals
      10.14.2 Clinics
      10.14.3 Ambulatory Surgical Centers
      10.14.4 Others
   10.15 Basis Point Share (BPS) Analysis By End-user
   10.16 Absolute $ Opportunity Assessment By End-user
   10.17 Market Attractiveness Analysis By End-user
Chapter 11 Europe Nitinol Based Medical Device Analysis and Forecast
   11.1 Introduction
   11.2 Europe Nitinol Based Medical Device Market Size Forecast by Country
      11.2.1 Germany
      11.2.2 France
      11.2.3 Italy
      11.2.4 U.K.
      11.2.5 Spain
      11.2.6 Russia
      11.2.7 Rest of Europe
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Europe Nitinol Based Medical Device Market Size Forecast By Product
      11.6.1 Nitinol Stents
      11.6.2 Nitinol Guidewires
      11.6.3 Nitinol Filters
      11.6.4 Nitinol Basket
      11.6.5 Nitinol Catheters
      11.6.6 Others
   11.7 Basis Point Share (BPS) Analysis By Product
   11.8 Absolute $ Opportunity Assessment By Product
   11.9 Market Attractiveness Analysis By Product
   11.10 Europe Nitinol Based Medical Device Market Size Forecast By Application
      11.10.1 Orthopedic
      11.10.2 Vascular
      11.10.3 Dental
      11.10.4 Gastroenterology
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis By Application
   11.12 Absolute $ Opportunity Assessment By Application
   11.13 Market Attractiveness Analysis By Application
   11.14 Europe Nitinol Based Medical Device Market Size Forecast By End-user
      11.14.1 Hospitals
      11.14.2 Clinics
      11.14.3 Ambulatory Surgical Centers
      11.14.4 Others
   11.15 Basis Point Share (BPS) Analysis By End-user
   11.16 Absolute $ Opportunity Assessment By End-user
   11.17 Market Attractiveness Analysis By End-user

Chapter 12 Asia Pacific Nitinol Based Medical Device Analysis and Forecast
   12.1 Introduction
   12.2 Asia Pacific Nitinol Based Medical Device Market Size Forecast by Country
      12.2.1 China
      12.2.2 Japan
      12.2.3 South Korea
      12.2.4 India
      12.2.5 Australia
      12.2.6 South East Asia (SEA)
      12.2.7 Rest of Asia Pacific (APAC)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Asia Pacific Nitinol Based Medical Device Market Size Forecast By Product
      12.6.1 Nitinol Stents
      12.6.2 Nitinol Guidewires
      12.6.3 Nitinol Filters
      12.6.4 Nitinol Basket
      12.6.5 Nitinol Catheters
      12.6.6 Others
   12.7 Basis Point Share (BPS) Analysis By Product
   12.8 Absolute $ Opportunity Assessment By Product
   12.9 Market Attractiveness Analysis By Product
   12.10 Asia Pacific Nitinol Based Medical Device Market Size Forecast By Application
      12.10.1 Orthopedic
      12.10.2 Vascular
      12.10.3 Dental
      12.10.4 Gastroenterology
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis By Application
   12.12 Absolute $ Opportunity Assessment By Application
   12.13 Market Attractiveness Analysis By Application
   12.14 Asia Pacific Nitinol Based Medical Device Market Size Forecast By End-user
      12.14.1 Hospitals
      12.14.2 Clinics
      12.14.3 Ambulatory Surgical Centers
      12.14.4 Others
   12.15 Basis Point Share (BPS) Analysis By End-user
   12.16 Absolute $ Opportunity Assessment By End-user
   12.17 Market Attractiveness Analysis By End-user
Chapter 13 Latin America Nitinol Based Medical Device Analysis and Forecast
   13.1 Introduction
   13.2 Latin America Nitinol Based Medical Device Market Size Forecast by Country
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of Latin America (LATAM)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Latin America Nitinol Based Medical Device Market Size Forecast By Product
      13.6.1 Nitinol Stents
      13.6.2 Nitinol Guidewires
      13.6.3 Nitinol Filters
      13.6.4 Nitinol Basket
      13.6.5 Nitinol Catheters
      13.6.6 Others
   13.7 Basis Point Share (BPS) Analysis By Product
   13.8 Absolute $ Opportunity Assessment By Product
   13.9 Market Attractiveness Analysis By Product
   13.10 Latin America Nitinol Based Medical Device Market Size Forecast By Application
      13.10.1 Orthopedic
      13.10.2 Vascular
      13.10.3 Dental
      13.10.4 Gastroenterology
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis By Application
   13.12 Absolute $ Opportunity Assessment By Application
   13.13 Market Attractiveness Analysis By Application
   13.14 Latin America Nitinol Based Medical Device Market Size Forecast By End-user
      13.14.1 Hospitals
      13.14.2 Clinics
      13.14.3 Ambulatory Surgical Centers
      13.14.4 Others
   13.15 Basis Point Share (BPS) Analysis By End-user
   13.16 Absolute $ Opportunity Assessment By End-user
   13.17 Market Attractiveness Analysis By End-user
Chapter 14 Middle East & Africa (MEA) Nitinol Based Medical Device Analysis and Forecast
   14.1 Introduction
   14.2 Middle East & Africa (MEA) Nitinol Based Medical Device Market Size Forecast by Country
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 UAE
      14.2.4 Rest of Middle East & Africa (MEA)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Middle East & Africa (MEA) Nitinol Based Medical Device Market Size Forecast By Product
      14.6.1 Nitinol Stents
      14.6.2 Nitinol Guidewires
      14.6.3 Nitinol Filters
      14.6.4 Nitinol Basket
      14.6.5 Nitinol Catheters
      14.6.6 Others
   14.7 Basis Point Share (BPS) Analysis By Product
   14.8 Absolute $ Opportunity Assessment By Product
   14.9 Market Attractiveness Analysis By Product
   14.10 Middle East & Africa (MEA) Nitinol Based Medical Device Market Size Forecast By Application
      14.10.1 Orthopedic
      14.10.2 Vascular
      14.10.3 Dental
      14.10.4 Gastroenterology
      14.10.5 Others
   14.11 Basis Point Share (BPS) Analysis By Application
   14.12 Absolute $ Opportunity Assessment By Application
   14.13 Market Attractiveness Analysis By Application
   14.14 Middle East & Africa (MEA) Nitinol Based Medical Device Market Size Forecast By End-user
      14.14.1 Hospitals
      14.14.2 Clinics
      14.14.3 Ambulatory Surgical Centers
      14.14.4 Others
   14.15 Basis Point Share (BPS) Analysis By End-user
   14.16 Absolute $ Opportunity Assessment By End-user
   14.17 Market Attractiveness Analysis By End-user
Chapter 15 Competition Landscape
   15.1 Nitinol Based Medical Device Market: Competitive Dashboard
   15.2 Global Nitinol Based Medical Device Market: Market Share Analysis, 2022
   15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      15.3.1 Abbott
      15.3.2 ENDOSMART
      15.3.3 Arthrex, Inc.
      15.3.4 B. Braun SE
      15.3.5 BD
      15.3.6 BIOTRONIK SE & Co. KG
      15.3.7 Boston Scientific Corporation
      15.3.8 COOK MEDICAL LLC
      15.3.9 Medtronic
      15.3.10 Nordson Corporation
      15.3.11 Olympus Corporation
      15.3.12 steris plc
      15.3.13 W. L. Gore & Associates, Inc.
      15.3.14 Zimmer Biomet

Purchase Premium Report

FAQ Section

Some frequently asked questions about this report!

The base year considered for the Global Nitinol Based Medical Device Market report is 2022. The complete analysis period is 2016 to 2031, wherein, 2016 to 2021 are the historic years, and the forecast is provided from 2023 to 2031.

The forecast year considered for the Global Nitinol Based Medical Device Market report is 2031.

Factors such as Recall of Medical Devices is expected to hinder the market.

The pandemic affected surgical practices significantly in the following ways: Elective surgeries postponed: Elective surgeries are non-urgent procedures that are scheduled in advance, such as bariatric (weight loss) surgery. Focus on urgent and emergency surgeries: Healthcare facilities redirected their attention and resources towards urgent and emergency surgeries, thus impacting the surgical procedures.

Major manufacturers include Abbott, ENDOSMART, Arthrex, Inc., B. Braun SE, BD, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, COOK MEDICAL LLC, Medtronic, Nordson Corporation, Olympus Corporation, steris plc, W. L. Gore & Associates, Inc., and Zimmer Biomet.

Factors such as government policies and cost of treatment are analyzed in the final report.

According to this Growth Market Reports report, the Global Nitinol Based Medical Device Market is likely to register a CAGR of 11.8% during the forecast period 2023-2031, with a projected valuation of USD ~46,274.6 million by the end of 2031.

Growing Prevalence of Cardiovascular Disease is the factors expected to drive the market growth during the forecast period.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst